AAAAAA

   
Results: 1-13 |
Results: 13
Determination of myloid antigen expression on childhood acute lymphoblastic leukaemia cells: Discrepancies using different monoclonal antibody clones
Authors: Firat, H Favier, R Adam, M Leverger, G Landman-Parker, J Cayre, Y Douay, L
Citation: H. Firat et al., Determination of myloid antigen expression on childhood acute lymphoblastic leukaemia cells: Discrepancies using different monoclonal antibody clones, LEUK LYMPH, 42(4), 2001, pp. 675-682
Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: Discrepancies using different monoclonal antibody clones
Authors: Firat, H Favier, R Adam, M Leverger, G Landman-Parker, J Cayre, Y Douay, L
Citation: H. Firat et al., Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: Discrepancies using different monoclonal antibody clones, LEUK LYMPH, 42(1-2), 2001, pp. 75-82
Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis
Authors: Ben-Arieh, SV Zimerman, B Smorodinsky, NI Yaacubovicz, M Schechter, C Bacik, I Gibbs, J Bennink, JR Yewdell, JW Coligan, JE Firat, H Lemonnier, F Ehrlich, R
Citation: Sv. Ben-arieh et al., Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis, J VIROLOGY, 75(21), 2001, pp. 10557-10562
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors
Authors: Scardino, A Alves, P Gross, DA Tourdot, S Graff-Dubois, S Angevin, E Firat, H Chouaib, S Lemonier, F Nadler, LM Cardoso, AA Kosmatopoulos, K
Citation: A. Scardino et al., Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors, EUR J IMMUN, 31(11), 2001, pp. 3261-3270
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A0201 transgenic, H-2 class IKO mice
Authors: Firat, H Tourdot, S Ureta-Vidal, A Scardino, A Suhrbier, A Buseyne, F Riviere, Y Danos, O Michel, ML Kosmatopoulos, K Lemonnier, FA
Citation: H. Firat et al., Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A0201 transgenic, H-2 class IKO mice, EUR J IMMUN, 31(10), 2001, pp. 3064-3074
Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin's lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells
Authors: Yao, M Fouillard, L Lemoine, FM Bouchet, S Firat, H Andreu, G Gorin, NC Douay, L Lopez, M
Citation: M. Yao et al., Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin's lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells, BONE MAR TR, 26(5), 2000, pp. 497-503
Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
Authors: Minev, B Hipp, J Firat, H Schmidt, JD Langlade-Demoyen, P Zanetti, M
Citation: B. Minev et al., Cytotoxic T cell immunity against telomerase reverse transcriptase in humans, P NAS US, 97(9), 2000, pp. 4796-4801
Ex vivo expansion of mobilized peripheral blood stem cells
Authors: Firat, H Douay, L
Citation: H. Firat et L. Douay, Ex vivo expansion of mobilized peripheral blood stem cells, BAIL CLIN H, 12(1-2), 1999, pp. 99-115
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIVCD8(+) cytotoxic T-cell epitopes
Authors: Woodberry, T Gardner, J Mateo, L Eisen, D Medveczky, J Ramshaw, IA Thomson, SA French, RA Elliot, SL Firat, H Lemonnier, FA Suhrbier, A
Citation: T. Woodberry et al., Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIVCD8(+) cytotoxic T-cell epitopes, J VIROLOGY, 73(7), 1999, pp. 5320-5325
An HLA-A2 polyepitope vaccine for melanoma immunotherapy
Authors: Mateo, L Gardner, J Chen, QY Schmidt, C Down, M Elliott, SL Pye, SJ Firat, H Lemonnier, FA Cebon, J Suhrbier, A
Citation: L. Mateo et al., An HLA-A2 polyepitope vaccine for melanoma immunotherapy, J IMMUNOL, 163(7), 1999, pp. 4058-4063
Phenotypical and functional characterization of the CD8(+) T cell repertoire of HLA-A2.1 transgenic, H-2K(bo)D(bo) double knockout mice
Authors: Ureta-Vidal, A Firat, H Perarnau, B Lemonnier, FA
Citation: A. Ureta-vidal et al., Phenotypical and functional characterization of the CD8(+) T cell repertoire of HLA-A2.1 transgenic, H-2K(bo)D(bo) double knockout mice, J IMMUNOL, 163(5), 1999, pp. 2555-2560
Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells
Authors: Lauvau, G Kakimi, K Niedermann, G Ostankovitch, M Yotnda, P Firat, H Chisari, FV van Endert, PM
Citation: G. Lauvau et al., Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells, J EXP MED, 190(9), 1999, pp. 1227-1239
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies
Authors: Firat, H Garcia-Pons, F Tourdot, S Pascolo, S Scardino, A Garcia, Z Michel, ML Jack, RW Jung, G Kosmatopoulos, K Mateo, L Suhrbier, A Lemonnier, FA Langlade-Demoyen, P
Citation: H. Firat et al., H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies, EUR J IMMUN, 29(10), 1999, pp. 3112-3121
Risultati: 1-13 |